
Feb 17, 2023
SWOG recently reported notable results from S1416 in breast cancer and S1815 in biliary tract cancers

Feb 17, 2023

Feb 10, 2023

Feb 3, 2023

Jan 30, 2023
S1416 trial results show PARP inhibitor benefit in "BRCA-like" triple-negative breast cancer

Jan 27, 2023

Jan 20, 2023
Nab-paclitaxel does not extend biliary tract cancer survival, but may benefit some